INTERNATIONAL PATENT: AMUNIX PHARMACEUTICALS, INC. FILES APPLICATION FOR "COMPOSITIONS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) IN COMBINATION WITH ANDROGEN RECEPTOR ANTAGONISTS"

GENEVA, Feb. 4 -- AMUNIX PHARMACEUTICALS, INC. (2 Tower PlaceSouth San Francisco, California 94080) filed a patent application (PCT/US2025/038896) for "COMPOSITIONS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) IN COMBINATION WITH ANDROGEN RECEPTOR ANTAGONISTS" on Jul 23, 2025. With publication no. WO/2026/024863, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHINN, Lawrence (c/o Amunix Pharmaceuticals, Inc.2 Tower PlaceSouth San Francisco, California 94080), DUBROVSKAYA, Viktoriya (c/o Amunix Pharmaceuticals, Inc...